Favorable response to lymphoblastoid interferon-alpha in children with chronic hepatitis C

Journal of Hepatology

Volumn 28, Issue 2, 1998, Pages 184-188

  Sawada, Atsushi ^a   Tajiri, Hitoshi ^a   Kozaiwa, Kosuke ^a   Guo, Wei ^a   Tada, Kanae ^a   Etani, Yuri ^a   Okada, Shintaro ^a   Sako, Masahiro ^b  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b OSAKA CITY GENERAL HOSPITAL   (Japan)

Author keywords

Hepatitis C virus; Interferon therapy; Liver histology; Side effect

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; LYMPHOBLAST INTERFERON;

ADOLESCENT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHILD; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; FEVER; HAIR LOSS; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER BIOPSY; MALE; NEUTROPENIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCORING SYSTEM; THROMBOCYTOPENIA; VIREMIA;

EID: 0032005872     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-8278(88)80003-5     Document Type: Article

References (20)

1. Bortolotti F, Giacchino R, Vajro P, Barbera C, Crivellaro C, Alberti A, et al. Recombinant interferon-alfa therapy in children with chronic hepatitis C. Hepatology. 22:1995;1623-1627.
2. Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC Jr, Perrillo RP. Treatment of chronic hepatitis C with recombinant interferon alfa: a multicenter randomized, controlled trial. N Engl J Med. 321:1989;1501-1506.
3. DiBisgeglie AM, Martin P, Kassianides C, Lisker-Melman M, Murray L, Waggoner J, et al. Recombinant interferon alfa therapy for chronic hepatitis C a randomized double-blind, placebo-controlled trial. N Engl J Med. 321:1989;1506-1510.
4. Shindo M, DiBisceglie AM, Hoofnagle JH. Long-term follow-up of patients with chronic hepatitis C treated with alfa-interferon. Hepatology. 15:1992;1013-1016.
5. Ruiz-Moreno M, Rua MJ, Castillo I, Garcia-Novo MD, Santos M, Navas S, et al. Treatment of children with chronic hepatitis C with recombinant interferon-alfa: a pilot study. Hepatology. 16:1992;882-885.
6. Iorio R, Penstati P, Porzio S, Fariello I, Guida S, Vegnente A. Lymphoblastoid interferon alfa treatment in chronic hepatitis C. Arch Dis Child. 74:1996;152-156.
7. Shibata M, Morishima T, Kudo T, Maki T, Maki S, Nagai Y. Serum hepatitis C virus sequences in posttransfusion non-A, non-B hepatitis. Blood. 77:1991;1157-1160.
8. Okamoto H, Okada S, Sugiyama Y, Tanaka T, Sugai Y, Akahane Y, et al. Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5′-noncoding region. J Exp Med. 60:1990;215-222.
9. Takehara T, Hayashi N, Mita E, Hagiwara H, Ueda K, Katayama K, et al. Detection of the minus strand of hepatitis C virus RNA by reverse transcription and polymerase chain reaction: implications for hepatitis C virus replication in infected tissue. Hepatology. 15:1992;387-390.
10. Kaneko S, Murakami S, Unoura M, Kobayashi K. Quantitation of hepatitis C virus RNA by competitive polymerase chain reaction. J Med Virol. 37:1992;278-282.
11. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol. 73:1992;673-679.
12. Tsukiyama-Kohara K, Yamaguchi K, Maki N, Ohta Y, Miki K, Mizokami M, et al. Antigenicities of group I and group II hepatitis C virus polypeptides-molecular basis of diagnosis. Virology. 192:1993;430-437.
13. Hanley JP, Jarvis LM, Andrews J, Dennis R, Hayes PC, Piris J, et al. Interferon treatment for chronic hepatitis C interferon in hemophiliacs. Influence of virus load, genotype, and liver pathology on response. Blood. 87:1996;1704-1709.
14. De Groote J, Desmet VJ, Gedigk P, Korb G, Popper H, Poulsen H, et al. A classification of chronic hepatitis. Lancet. ii:1968;626-628.
15. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1:1981;431-435.
16. Hagiwara H, Hayashi N, Ueda K, Takehara T, Kasahara A, Fusamoto H, et al. Detection of hepatitis C virus RNA in serum of patients with chronic hepatitis C treated with interferon-alfa. Hepatology. 15:1992;37-41.
17. Lau JYN, Davis GL, Kniffen J, Qian KP, Urdea MS, Chan CS, et al. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet. 341:1993;1501-1504.
18. Cesaro S, Rossetti F, De Moliner L, Zanesco L, Bortolotti F. Interferon for chronic hepatitis C in patients cured for malignancy. Eur J Pediatr. 153:1994;659-662.
19. Kanai K, Kako M, Okamoto H. HCV genotypes in chronic hepatitis C and response to interferon. Lancet. 339:1992;1543.
20. Balart LA, Perrillo R, Roddenberry J, Regenstein F, Shim KS, Shieh C, et al. Hepatitis C RNA in liver of chronic hepatitis C patients before and after interferon alfa treatment. Gastroenterology. 104:1993;1472-1477.